The combination of histone deacetylase inhibitors with immune-stimulating antibodies has potent anti-cancer effects
Alison C West, Ailsa J Christiansen, Mark J Smyth, Ricky W Johnstone
OncoImmunology | LANDES BIOSCIENCE | Published : 2012
The R.W.J. laboratory has collaborative research grants from Merck & Co and Novartis for studies involving vorinostat and panobinostat, respectively.